Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Dec 2011

Masuda Ken, Takano Atsushi, Oshita Hideto, Akiyama Hirohiko, Tsuchiya Eiju, Kohno Nobuoki, Nakamura Yusuke, Daigo Yataro

Abstract excerpt

PURPOSE: This study aims to identify molecules that might be useful as diagnostic/prognostic biomarkers and as targets for the development of new molecular therapies for lung cancer. EXPERIMENTAL DESIGN: We screened for genes that were highly transactivated in a large proportion of 120 lung cancers by means of a cDNA microarray representing 27,648 genes and found chondrolectin (CHODL) as a candidate. Tumor tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Chlorocebus aethiops

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COS Cells

Share to Kaplan-Meier Estimate

Share to Lectins, C-Type

Share to Multivariate Analysis

Share to RNA Interference

Share to Tissue Array Analysis

Source

Identifiers

PMID: 22016508
DOI: 10.1158/1078-0432.CCR-11-0619

Genes

CHODL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.PMID 22016508Read ↗

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.Semantic proximity Read ↗

Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene.Semantic proximity Read ↗

Identification of Epstein-Barr Virus–Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung CancerSemantic proximity Read ↗

Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survivalSemantic proximity Read ↗

Extracellular matrix functions in lung cancer.Semantic proximity Read ↗

Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancersSemantic proximity Read ↗

Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray.Semantic proximity Read ↗

Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor PrognosisSemantic proximity Read ↗

Overexpression of crkl correlates with poor prognosis and cell proliferation in non‐small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.